MetaCap

Azora Therapeutics Quarterly Income Statement

NASDAQ: AZRHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.85-0.02 (-0.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Azora Therapeutics revenue and earnings

Azora Therapeutics reported a net loss of $64.6 million, compared with a loss of $1.8 million a year earlier. Diluted earnings per share came in at -$4.52.

Summary generated from market data by MetaCap's automated system. Methodology

Azora Therapeutics income statement (quarterly)

Azora Therapeutics quarterly income statement
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q2 20242024-03-31Q4 20232023-12-31
Operating Expenses7.53M52.02M2.00M1.89M1.76M1.88M2.27M1.94M2.21M2.29M1.85M1.78M
Research & Development1.77M440.00K432.53K619.67K521.00K732.00K746.89K730.79K1.03M1.01M454.28K264.44K
Operating Income-7.53M-52.02M-2.00M-1.89M-1.76M-1.88M-2.27M-1.94M-2.21M-2.29M-1.85M-1.78M
Other Income (Expense)-57.03M36.00K-20.91K-110.71K-30.00K-76.00K38.49K-130.06K19.67K-171.07K-4.63M-120.60K
Pretax Income———————-2.07M-2.19M-2.46M—-1.90M
Net Income-64.56M-51.99M-2.02M-2.00M-1.79M-1.96M-2.23M-2.07M-2.19M-2.46M-6.48M-1.92M
Net Income growth (YoY)—————————-325.99%——
EPS (Basic)-4.52-11.25-1.483.22-2.02-4.61-8.52-64.85-0.38-0.59-2.19-3.27
EPS (Diluted)-4.52-11.25-1.483.22-2.02-4.61-8.52-64.85-0.38-0.59-2.19-3.27
Shares Outstanding (Basic)14.30M4.62M1.37M—886.85K424.91K261.59K—5.84M———
Shares Outstanding (Diluted)14.30M4.62M1.37M—886.85K424.91K261.59K—5.84M4.18M2.95M—

This table shows 12 quarterly periods of Azora Therapeutics's income statement, from Q3 2026 back to Q4 2023, across 11 line items including operating expenses, research & development, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow AZR's reporting calendar. What is a income statement?

More financial data